Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cannabinoid receptor 1 and cannabinoid receptor 2 are members of the G protein-coupled receptor family that mediate the effects of endogenous cannabinoids (anandamide, 2-AG), phytocannabinoids (THC, CBD), and synthetic cannabinoids. Both receptors are present in the skin, with complementary patterns in epidermal keratinocytes, sebaceous glands, hair follicles, mast cells, and immune cells. They regulate skin barrier formation, keratinocyte growth, immune and inflammatory responses, and sebum production. Dysregulation of these receptors is implicated in various dermatological disorders such as atopic dermatitis, psoriasis, acne, and certain tumors. Modulation of these receptors is being explored therapeutically for inflammatory and proliferative skin diseases
Agonism or antagonism of CB1/CB2 receptors to modulate inflammatory responses. Inhibition of keratinocyte proliferation or induction of apoptosis in pathological states. Modulation of sebum/lipid production via sebocytes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cannabinoid receptor 1 and cannabinoid receptor 2 (CB1, CB2).